Skip to main content

Published locations for CML-CP: BCR-ABL1 transcript doubling time predicts TFR failure after imatinib discontinuation

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CML-CP: BCR-ABL1 transcript doubling time predicts TFR failure after imatinib discontinuation

User login

  • Reset your password
  • /content/cml-cp-bcr-abl1-transcript-doubling-time-predicts-tfr-failure-after-imatinib-discontinuation
  • /hematology-oncology/article/246646/cml/cml-cp-bcr-abl1-transcript-doubling-time-predicts-tfr-failure